Perimenopause, Neurodivergence and the Female Brain
£0.00
WEBINAR
Session starts: 7pm
Location: Microsoft Teams
Event Agenda
| Time | Agenda | Speaker |
|---|---|---|
| 7:00-7:15 | Symposium | TBC |
| 7:15-7:45 | Explore how hormonal changes and perimenopause interact with neurodivergence, often revealing previously undiagnosed ADHD in women ( Non promotional ) | Dr. Helen Wall |
| 7:45-8:15 | Identify practical approaches for assessment, hormone therapy, and holistic support for women in midlife ( Non promotional ) | Dr. Helen Wall |
Why Should Healthcare Professionals Attend This Webinar?
As awareness of ADHD and other forms of neurodivergence grows, many clinicians are encountering midlife women experiencing cognitive and emotional changes, such as distractibility, overwhelm, and emotional dysregulation, that perimenopause alone doesn’t fully explain.
This session explores the intersection between perimenopause and neurodivergence, particularly ADHD, highlighting how hormonal fluctuations influence dopamine regulation, executive function, and emotional resilience. Dr Helen Wall will discuss how these shifts can “unmask” underlying neurodivergent traits that may have been hidden for decades, and how targeted use of hormone replacement therapy (HRT) products, including oestrogen and progesterone-based treatments may support cognitive stability, improve mood regulation, and enhance overall wellbeing when used alongside neurodivergence-informed care strategies.
By attending this session, participants will be able to:
-
Recognise how perimenopausal hormonal changes can unmask or worsen ADHD symptoms in midlife women.
-
Understand how oestrogen and progesterone influence focus, mood, and emotional regulation.
-
Identify when to consider ADHD assessment and the role of HRT products such as oestrogen, progesterone, or combined therapies in supporting wellbeing.
Key Benefits
This CPD-accredited webinar, delivered by Dr Helen Wall, will provide healthcare professionals with:
-
Clinical confidence – recognise signs, assess appropriately, and interpret findings.
-
Practical management tools – understand monitoring needs and referral pathways.
-
Evidence-based insights – apply current UK research and guidance in practice.
Attendees will gain the knowledge to better support perimenopausal women with neurodivergence, address health inequalities, and improve patient outcomes.
Additional Information
-
The webinar will be recorded and made available to our subscribers.
-
CPD certificates will be issued to all attendees.
-
The Teams link can be found in your Clinilink account (please ensure you are logged in to access it).
Meet the Speaker
Dr. Helen Wall MBBS
GP Senior Partner | Clinical Director of Population Health (GM) | Visiting Professor | Media GP
A familiar face on UK television, Helen is Resident GP on BBC Breakfast, a regular contributor to Woman Magazine, and a trusted voice on health, menopause, and wellbeing. A registered BMS menopause specialist, she also runs an NHS menopause clinic and champions women’s health and neurodiversity awareness.
Recognised with multiple honours, including Woman of the Year (She Inspires Awards 2022), an Honorary Doctorate in Public Health, and a Visiting Professorship at the University of Manchester. Helen is a respected leader and communicator in healthcare.
She speaks widely on topics such as leadership, communication in medicine, navigating the NHS, and women’s health.Follow Helen on Instagram @doctorhelenwall
Website: www.drhelenwall.co.uk






